Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11752198 GLP-1 compositions and uses thereof

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Joakim Lundqvist

Michael Duelund Soerensen

Eva Horn Moeller

Date of Patent

September 12, 2023

Patent Application Number

17115773

Date Filed

December 8, 2020

Patent Citations

US Patent 7112567 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders

US Patent 8129343 Acylated GLP-1 compounds

US Patent 8158583 Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia

US Patent RE43834 Injection syringe

US Patent 8541470 Topical pharmaceutical formulation

US Patent 8846618 Stable formulation of modified GLP-1

US Patent 9133276 Prodrugs comprising an exendin linker conjugate

US Patent 9217022 GLP-1 receptor agonist compounds having stabilized regions

...

Patent Primary Examiner

Sudhakar Katakam

CPC Code

The present invention relates to pharmaceutical compositions of the GLP-1 peptide semaglutide comprising no more than 0.01% (w/w) phenol, their preparation, kits comprising such compositions as well as uses thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11752198 GLP-1 compositions and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.